MicroRNA-29a Functions as a Tumor Suppressor and Increases Cisplatin Sensitivity by Targeting NRAS in Lung Cancer

microRNA-145-3p inhibits non-small cell lung cancer cell migration and invasion by targeting PDK1 via the mTOR signaling pathway

(2017) Gui-Min Chen et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

miR-202 functions as a tumor suppressor in non-small cell lung cancer by targeting STAT3

(2017) Zhonghai Zhao et al.   Molecular Medicine Reports

Downregulation of miR-218 contributes to epithelial–mesenchymal transition and tumor metastasis in lung cancer by targeting Slug/ZEB2 signaling

(2017) Z-M Shi et al.   ONCOGENE

miR-29a suppresses MCF-7 cell growth by downregulating tumor necrosis factor receptor 1

(2017) Yiling Zhao et al.   TUMOR BIOLOGY

MicroRNA-29a functions as a potential tumor suppressor through directly targeting CDC42 in non-small cell lung cancer

(2017) Yongqiang Li et al.   Oncology Letters

miRNA-29a as a tumor suppressor mediates PRIMA-1Met-induced anti-myeloma activity by targeting c-Myc

(2016) Manujendra N. Saha et al.   Oncotarget

Downregulation of ATG14 by EGR1-MIR152 sensitizes ovarian cancer cells to cisplatin-induced apoptosis by inhibiting cyto-protective autophagy

(2015) Jun He et al.   Autophagy

Global cancer statistics, 2012

(2015) Lindsey A. Torre et al.   CA-A CANCER JOURNAL FOR CLINICIANS

The emerging role of microRNAs in resistance to lung cancer treatments

(2015) Lauren MacDonagh et al.   CANCER TREATMENT REVIEWS

MicroRNA-497 inhibits tumor growth and increases chemosensitivity to 5-fluorouracil treatment by targeting KSR1

(2015) Lin Wang et al.   Oncotarget

MiR-143 acts as a tumor suppressor by targeting N-RAS and enhances temozolomide-induced apoptosis in glioma

(2015) Lin Wang et al.   Oncotarget

Impact of microRNAs in Resistance to Chemotherapy and Novel Targeted Agents in Non-Small Cell Lung Cancer

(2014) Christian Rolfo et al.   CURRENT PHARMACEUTICAL BIOTECHNOLOGY

MicroRNA-7 sensitizes non-small cell lung cancer cells to paclitaxel

(2014) RONGHUA LIU et al.   Oncology Letters

MicroRNA-21: a therapeutic target for reversing drug resistance in cancer

(2013) Liu Hong et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Expression of Notch-1 and its clinical significance in different histological subtypes of human lung adenocarcinoma

(2013) Jiayuan Huang et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

SOX7 is down-regulated in lung cancer

(2013) Takahide Hayano et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Combined targeting of MEK and PI3K/mTOR effector pathways is necessary to effectively inhibit NRAS mutant melanoma in vitro and in vivo

(2013) C. Posch et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Genetic alterations in the RAS/RAF/mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling pathways in the follicular variant of papillary thyroid carcinoma

(2010) Libero Santarpia et al.   CANCER